Stay updated with breaking news from Daniel vasella. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Numab raises $111M to challenge Genmab, BioNTech for emerging PD-L1 opportunity fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
«Solch hohe Boni sind Gift» – wie die Pandemie die Boni-Debatte befeuert watson.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from watson.ch Daily Mail and Mail on Sunday newspapers.
Ghana's mPharma partners with Ethiopian conglomerate to enter its eighth market – TechCrunch techcrunch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from techcrunch.com Daily Mail and Mail on Sunday newspapers.
Coronavirus: L'erreur fatale des pharmas suisses et de Berne 20min.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 20min.ch Daily Mail and Mail on Sunday newspapers.
and mckenzie and company shows a stunning difference among countries with regard to health care efficiency. for example, smoking rates are higher in france than in the united states. so the french population has higher rates of lung disease. yet, the french system is able to treat the disease far more effectively than happens in the united states. its levels of severity and fatality are three times lower than in this country. and yet, france spends eight times less on treatments per person than the u.s. system, eight times less. consider britain, which handles diabetes far more effectively than the u.s. while spending less than half of what we spend per person. the british system is five times more effective in managing diabetes than the united states is. to understand this issue better i spoke with daniel vasella, chairman and former chief executive of novartis and physician by training. he s also frankly pro-market and pro-american, both of which occasionally have mad ....